Trial Information
Inclusion Criteria:
- Patients with SCC of the head and neck
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
safety
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Nasser Al Rajhi, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
KFSH&RC
Authority:
United States: Institutional Review Board
Study ID:
RAC#0981-019
NCT ID:
NCT00534950
Start Date:
September 2007
Completion Date:
September 2015
Related Keywords:
- Carcinoma, Squamous Cell
- Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck
- Carcinoma
- Carcinoma, Squamous Cell